Why the Small Details Reveal Everything About Your CDMO Partner with Frank Sorce

In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Frank Sorce, Chief Commercial Officer at UPM Pharmaceuticals, to share insights into the critical decisions involved in selecting contract development and manufacturing organizations (CDMOs).Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors.Pharma Sessions is hosted by Jonathan KaskeyFollow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/Or join the Pharma Sessions Substack:www.pharmasessions.substack.comEpisode Resources:Frank Sorce on LinkedInUPM Pharmaceuticals WebsiteJonathan Kaskey on LinkedInXSUNT Corporation Website Pharma Sessions is hosted by Jonathan KaskeyFollow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/Or join the Pharma Sessions Substack:www.pharmasessions.substack.com